Logo image of METX

BTC DIGITAL LTD (METX) Stock Fundamental Analysis

NASDAQ:METX - KYG6055H1552 - Common Stock

2.03 USD
+0.17 (+9.14%)
Last: 9/28/2023, 8:00:13 PM
Fundamental Rating

3

Overall METX gets a fundamental rating of 3 out of 10. We evaluated METX against 71 industry peers in the Diversified Consumer Services industry. There are concerns on the financial health of METX while its profitability can be described as average. METX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

METX had positive earnings in the past year.
In the past year METX has reported a negative cash flow from operations.
METX had negative earnings in 4 of the past 5 years.
In the past 5 years METX always reported negative operating cash flow.
METX Yearly Net Income VS EBIT VS OCF VS FCFMETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -100M -200M -300M -400M -500M

1.2 Ratios

METX has a better Return On Assets (25.33%) than 97.01% of its industry peers.
The Return On Equity of METX (39.87%) is better than 95.52% of its industry peers.
METX has a better Return On Invested Capital (4.11%) than 67.16% of its industry peers.
Industry RankSector Rank
ROA 25.33%
ROE 39.87%
ROIC 4.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
METX Yearly ROA, ROE, ROICMETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -500 -1K -1.5K

1.3 Margins

METX has a Profit Margin of 64.97%. This is amongst the best in the industry. METX outperforms 100.00% of its industry peers.
With a decent Operating Margin value of 8.85%, METX is doing good in the industry, outperforming 70.15% of the companies in the same industry.
METX has a worse Gross Margin (14.94%) than 86.57% of its industry peers.
Industry RankSector Rank
OM 8.85%
PM (TTM) 64.97%
GM 14.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
METX Yearly Profit, Operating, Gross MarginsMETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so METX is destroying value.
METX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
METX Yearly Shares OutstandingMETX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 10M 20M 30M 40M 50M
METX Yearly Total Debt VS Total AssetsMETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -5.42, we must say that METX is in the distress zone and has some risk of bankruptcy.
METX's Altman-Z score of -5.42 is on the low side compared to the rest of the industry. METX is outperformed by 86.57% of its industry peers.
METX has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
METX has a better Debt to Equity ratio (0.05) than 61.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -5.42
ROIC/WACC0.84
WACC4.88%
METX Yearly LT Debt VS Equity VS FCFMETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 200M -200M 400M -400M

2.3 Liquidity

A Current Ratio of 1.27 indicates that METX should not have too much problems paying its short term obligations.
METX has a Current ratio (1.27) which is comparable to the rest of the industry.
METX has a Quick Ratio of 1.27. This is a normal value and indicates that METX is financially healthy and should not expect problems in meeting its short term obligations.
METX has a Quick ratio (1.27) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
METX Yearly Current Assets VS Current LiabilitesMETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 111.48% over the past year.
EPS 1Y (TTM)111.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
METX Yearly Revenue VS EstimatesMETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 200M 400M 600M 800M
METX Yearly EPS VS EstimatesMETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 -50 -100 -150 -200 -250

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.83, the valuation of METX can be described as very cheap.
Based on the Price/Earnings ratio, METX is valued cheaply inside the industry as 95.52% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.24, METX is valued rather cheaply.
Industry RankSector Rank
PE 3.83
Fwd PE N/A
METX Price Earnings VS Forward Price EarningsMETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

METX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. METX is cheaper than 73.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.59
METX Per share dataMETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for METX!.
Industry RankSector Rank
Dividend Yield N/A

BTC DIGITAL LTD

NASDAQ:METX (9/28/2023, 8:00:13 PM)

2.03

+0.17 (+9.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-02 2023-10-02
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change-99.96%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap42.39M
Analysts82.86
Price Target91.8 (4422.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)304.04%
Min Revenue beat(2)304.04%
Max Revenue beat(2)304.04%
Revenue beat(4)2
Avg Revenue beat(4)641.74%
Min Revenue beat(4)304.04%
Max Revenue beat(4)979.45%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.83
Fwd PE N/A
P/S 3.79
P/FCF N/A
P/OCF N/A
P/B 2.33
P/tB 2.33
EV/EBITDA 8.59
EPS(TTM)0.53
EY26.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.81
FCFYN/A
OCF(TTM)-1.4
OCFYN/A
SpS0.53
BVpS0.87
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 25.33%
ROE 39.87%
ROCE 5.43%
ROIC 4.11%
ROICexc 4.12%
ROICexgc 4.12%
OM 8.85%
PM (TTM) 64.97%
GM 14.94%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr 212.53%
Cap/Sales 75.02%
Interest Coverage 44.86
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -5.42
F-Score4
WACC4.88%
ROIC/WACC0.84
Cap/Depr(3y)150.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)111.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y206.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.38%
OCF growth 3YN/A
OCF growth 5YN/A